ADHD Medications: Amphetamines vs. Methylphenidates - Efficacy, Risks, and Best Practices

A thorough comparison of amphetamines and methylphenidate, focusing on efficacy, tolerability, psychiatric risks, and adult ADHD diagnosis.
Content written by: Chris Aiken, MD
💡Carlat Webinars: https://www.thecarlatreport.com/blogs...
📖Subscribe to The Carlat Journal: https://www.thecarlatreport.com/products
➡️Earn CME Credits for this video: https://thecarlatreport.com/blogs/3-c...

================

Follow Carlat:
🔴SUBSCRIBE ►    / @thecarlatreport  
➡️Twitter: / CarlatPsych

================

A 30-minute webinar for CME credit by Chris Aiken, MD, Editor-in-Chief of The Carlat Psychiatry Report. Dr. Aiken is a practicing psychiatrist in Winston-Salem, NC; director of the Mood Treatment Center in North Carolina; and Assistant Professor NYU Langone Department of Psychiatry.

Highlights
🧠 Mechanism: Amphetamines release dopamine, while methylphenidate blocks its reuptake.
📊 Efficacy: Meta-analyses show amphetamines generally have a greater effect size than methylphenidate.
💊 Tolerability: Methylphenidate is better tolerated with fewer side effects compared to amphetamines.
⚠️ Psychiatric Risks: Amphetamines may pose higher risks for psychosis and mania, especially in vulnerable populations.
🔍 Diagnosis: Adult ADHD diagnosis is complex; symptoms can overlap with other psychiatric disorders.
🏥 Treatment: Methylphenidate is often preferred as first-line treatment in adults due to its safety profile.
📈 Trends: Historical data shows a shift in stimulant prescriptions from amphetamines to methylphenidate in adults.
Key Insights
⚙️ Mechanism of Action: Understanding the differing mechanisms of amphetamines and methylphenidate is crucial for effective treatment choices. Amphetamines provide a more immediate increase in dopamine, which may lead to stronger effects but also a higher potential for side effects. 🧠

📈 Efficacy Differences: While amphetamines generally demonstrate a larger effect size, individual responses vary. Some patients may find methylphenidate more effective, emphasizing the need for personalized treatment approaches. 📊

😌 Tolerability and Side Effects: Methylphenidate tends to be better tolerated than amphetamines, suggesting it may be a safer option for patients, particularly those with complex comorbidities. 💊

⚠️ Psychiatric Risks: The risk of developing psychosis or mania is a significant concern, particularly with amphetamines. This highlights the importance of closely monitoring patients with a history of psychiatric disorders. ⚠️

🧩 Complex Diagnosis: The diagnosis of adult ADHD can be challenging due to overlapping symptoms with other conditions like PTSD or bipolar disorder, necessitating thorough assessments. 🔍

🏥 First-Line Treatment: Methylphenidate is often recommended as the first-line treatment in adults due to its favorable side effect profile, reflecting a shift in prescribing practices. 🏥

📜 Historical Context: Understanding the historical prescribing trends of stimulants can inform current practices and help avoid potential biases towards amphetamines. 📈